Kohyama K, Kato H, Okada H, Ishihara T, Yasue Y, Kamidani R
Contemp Clin Trials Commun. 2024; 42:101375.
PMID: 39398328
PMC: 11470421.
DOI: 10.1016/j.conctc.2024.101375.
Buczek-Thomas J, Rich C, Nugent M
Int J Mol Sci. 2019; 20(20).
PMID: 31614727
PMC: 6829205.
DOI: 10.3390/ijms20205065.
Dzvova N, Colmer-Hamood J, Griswold J, Hamood A
BMC Microbiol. 2017; 17(1):233.
PMID: 29246112
PMC: 5732420.
DOI: 10.1186/s12866-017-1141-0.
Weiss R, Esko J, Tor Y
Org Biomol Chem. 2017; 15(27):5656-5668.
PMID: 28653068
PMC: 5567684.
DOI: 10.1039/c7ob01058c.
Ribatti D
Pharmaceuticals (Basel). 2016; 3(3):482-513.
PMID: 27713265
PMC: 4033966.
DOI: 10.3390/ph3030482.
A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2).
Paluck S, Nguyen T, Lee J, Maynard H
Biomacromolecules. 2016; 17(10):3386-3395.
PMID: 27580376
PMC: 5059753.
DOI: 10.1021/acs.biomac.6b01182.
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.
Chiodelli P, Bugatti A, Urbinati C, Rusnati M
Molecules. 2015; 20(4):6342-88.
PMID: 25867824
PMC: 6272510.
DOI: 10.3390/molecules20046342.
Structural basis of heparan sulfate-specific degradation by heparinase III.
Dong W, Lu W, McKeehan W, Luo Y, Ye S
Protein Cell. 2012; 3(12):950-61.
PMID: 23011846
PMC: 4875378.
DOI: 10.1007/s13238-012-2056-z.
Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells.
Lamorte S, Ferrero S, Aschero S, Monitillo L, Bussolati B, Omede P
Leukemia. 2011; 26(5):1081-90.
PMID: 22024722
PMC: 3356559.
DOI: 10.1038/leu.2011.290.
Endothelial cell capture of heparin-binding growth factors under flow.
Zhao B, Zhang C, Forsten-Williams K, Zhang J, Fannon M
PLoS Comput Biol. 2010; 6(10):e1000971.
PMID: 21060855
PMC: 2965741.
DOI: 10.1371/journal.pcbi.1000971.
Extracellular matrix proteins and tumor angiogenesis.
Campbell N, Kellenberger L, Greenaway J, Moorehead R, Linnerth-Petrik N, Petrik J
J Oncol. 2010; 2010:586905.
PMID: 20671917
PMC: 2910498.
DOI: 10.1155/2010/586905.
Differential effects of Heparitinase I and Heparitinase III on endothelial tube formation in vitro.
Raman K, Kuberan B
Biochem Biophys Res Commun. 2010; 398(2):191-3.
PMID: 20599743
PMC: 2924581.
DOI: 10.1016/j.bbrc.2010.06.055.
Phage display-derived peptides for osteosarcoma imaging.
Sun X, Niu G, Yan Y, Yang M, Chen K, Ma Y
Clin Cancer Res. 2010; 16(16):4268-77.
PMID: 20570932
PMC: 2921467.
DOI: 10.1158/1078-0432.CCR-10-0968.
Heparan sulfate separation, sequencing, and isomeric differentiation: ion mobility spectrometry reveals specific iduronic and glucuronic acid-containing hexasaccharides.
Schenauer M, Meissen J, Seo Y, Ames J, Leary J
Anal Chem. 2009; 81(24):10179-85.
PMID: 19925012
PMC: 2810830.
DOI: 10.1021/ac902186h.
Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.
Babu P, Kuberan B
Anal Biochem. 2009; 396(1):124-32.
PMID: 19732739
PMC: 2791463.
DOI: 10.1016/j.ab.2009.08.036.
High yield, purity and activity of soluble recombinant Bacteroides thetaiotaomicron GST-heparinase I from Escherichia coli.
Luo Y, Huang X, McKeehan W
Arch Biochem Biophys. 2007; 460(1):17-24.
PMID: 17346663
PMC: 1993911.
DOI: 10.1016/j.abb.2007.01.029.
Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.
Liu D, Shriver Z, Venkataraman G, El Shabrawi Y, Sasisekharan R
Proc Natl Acad Sci U S A. 2002; 99(2):568-73.
PMID: 11805315
PMC: 117346.
DOI: 10.1073/pnas.012578299.
Angiogenesis-dependent diseases and angiogenesis therapy.
Timar J, Dome B, Fazekas K, JANOVICS A, Paku S
Pathol Oncol Res. 2001; 7(2):85-94.
PMID: 11458270
DOI: 10.1007/BF03032573.
Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.
Shriver Z, Raman R, Venkataraman G, Drummond K, Turnbull J, Toida T
Proc Natl Acad Sci U S A. 2000; 97(19):10359-64.
PMID: 10984531
PMC: 27029.
DOI: 10.1073/pnas.97.19.10359.
Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.
Rhomberg A, Shriver Z, Biemann K, Sasisekharan R
Proc Natl Acad Sci U S A. 1998; 95(21):12232-7.
PMID: 9770469
PMC: 22814.
DOI: 10.1073/pnas.95.21.12232.